Pipobroman
![]() | |
Clinical data | |
---|---|
Trade names | Vercite, Vercyte |
AHFS/Drugs.com | International Drug Names |
ATC code | L01AX02 (WHO) |
Identifiers | |
| |
CAS Number |
54-91-1 ![]() |
PubChem (CID) | 4842 |
IUPHAR/BPS | 7271 |
DrugBank |
DB00236 ![]() |
ChemSpider |
4676 ![]() |
UNII |
6Q99RDT97R ![]() |
KEGG |
D00467 ![]() |
ChEMBL |
CHEMBL1585 ![]() |
Chemical and physical data | |
Formula | C10H16Br2N2O2 |
Molar mass | 356.054 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
Pipobroman (trade names Vercite, Vercyte) is an anti-cancer drug that probably acts as an alkylating agent.[1] It is marketed by Abbott Laboratories.[2]
References
- ↑ Passamonti, F.; Lazzarino, M. (2003). "Treatment of Polycythemia Vera and Essential Thrombocythemia: The Role of Pipobroman". Leukemia & Lymphoma. 44 (9): 1483–1488. doi:10.3109/10428190309178768. PMID 14565648.
- ↑ Drugs.com: Pipobroman
This article is issued from Wikipedia - version of the 6/7/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.